Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Understand when to use Zero Based Budgeting versus Traditional budgeting, with scenarios where each approach delivers the most value and clarity.
23,185 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A six-year analysis ties CEO ego cues to push for in-person work, highlighting how office-first power dynamics influe...
SharpLink Gaming resumes ETH purchases after eight months, fueling a renewed ethereum price prediction: forgotten con...
A remarriage at 62 does not automatically end survivor benefits. The aging rule remains in effect, allowing many wido...
Target is adopting a points-based attendance policy for frontline workers, starting September, with strict penalties ...
As July approaches, a seasoned investor lays out why Apple sits at the center of their biggest July bet, citing the S...
Analysts warn that the CLARITY Act's odds of passing have fallen below 50% as the Senate's August recess approaches. ...
Retail traders who chased celebrity-backed crypto deals tied to a high-profile political name are confronting losses ...
Analysts survey a pivot in AI monetization that could revive the Magnificent Seven's earnings trajectory in H2 2026, ...
As AI infrastructure expands beyond GPUs, investors ask whether Nvidia is undervalued or overvalued — or perhaps both...
The spotlight in AI investing is shifting from screens to factories. The BOTZ ETF is positioning itself to ride a wav...
Micron Technology presses the AI memory story, delivering strong margins and cloud demand while facing volatility and...